Health and Healthcare
5864 Articles
Amgen and Xencor have entered into a research and license agreement to develop and commercialize novel therapeutics in the areas…
Intra-Cellular Therapies announced positive results from the first Phase 3 clinical trial of ITI-007 for the treatment of patients with…
ThinkstockTwo private companies in the healthcare sector, Penumbra Inc. and RegenXBio Inc., are planning on going public in later this…
Shares of Evoke Pharma rose in the market on Tuesday in the wake of solid draft guidance for its Phase…
Sientra has filed with the U.S. Securities and Exchange Commission (SEC) to update the terms for its secondary offering.
GW Pharmaceuticals is making great strides in the field of medicine with its most recent trial of Cannabidiol in patients…
Xenoport made waves in Tuesday morning’s premarket trading session on news of positive clinical trial results.
Dimension Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Raptor Pharmaceuticals saw its shares approach its 52-week low in Monday's premarket, after missed results in a Phase 2 study.
Over the past week, a few biotech companies made absolutely massive runs with at least 25% gains.
Arrowhead Research made waves in the market on Friday afternoon on positive developments surrounding its ARC-HIF2.
The short interest data have been released for the August 31 settlement date, and for the selected pharmaceutical stocks, short…
In a new and very comprehensive report, Jefferies starts coverage on biotechs with some very targeted stock selections.
The short interest data are out for the August 31 settlement date. Short interest in the selected biotech stocks increased…
ThinkstockAbbVie Inc. (NYSE: ABBV) has continued to push forward over the past year and shares are actually up 7.3% in…
Our top personal finance-related articles today. Your wallet will thank you later.